Suchergebnisse - "Motoi, Noriko"

PubPharm (4)

1

Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients

enthalten in: Clinical lung cancer | 2022

von Shimoda, Y. | Shibaki, R. | Yoshida, T. | +12

2

Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma

enthalten in: Clinical lung cancer | 2021

von Shirasawa, M. | Yoshida, T. | Takayanagi, D. | +16

3

Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC

enthalten in: Clinical lung cancer | 2021

von Takeyasu, Y. | Yoshida, T. | Shibaki, R. | +7

4

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

enthalten in: Clinical lung cancer | 2017

von Sakakibara, R. | Inamura, K. | Tambo, Y. | +13

1
[1]